Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
The AAPS Journal|October 24, 2009
Pharmacokinetic and pharmacodynamic modeling of a monoclonal antibody antagonist of glucagon receptor in male ob/ob miceYvonne Y Lau, Peiming Ma, Leonid Gibiansky, et al.
Anesthesiology|September 30, 2005
AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safetyMichel M R F Struys, Ann L G Vanluchene, Ekaterina Gibiansky, et al.
Clinical Pharmacology and Therapeutics|February 12, 2025
Optimal Dosing Regimen for Epcoritamab, a Subcutaneous Bispecific Antibody, in Relapsed or Refractory Large B-Cell LymphomaTommy Li, Leonid Gibiansky, Apurvasena Parikh, et al.
Clinical Pharmacology in Drug Development|February 19, 2020
Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon-γ-Induced Protein 10, BMS-986184, in Healthy Participants to Guide Therapeutic DosingWeiguo Cai, Tarek A Leil, Leonid Gibiansky, et al.
Anesthesiology|September 30, 2005
AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokineticsEkaterina Gibiansky, Michel M R F Struys, Leonid Gibiansky, et al.
Clinical Pharmacology and Therapeutics|May 27, 2021
Quantitative Clinical Pharmacology Supports the Bridging From i.v. Dosing and Approval of s.c. Rituximab in B-Cell Hematological MalignanciesCandice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, et al.
British Journal of Clinical Pharmacology|August 19, 2020
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimizationStefan Sturm, Annabelle Lemenuel-Diot, Kashyap Patel, et al.
Clinical Pharmacokinetics|March 17, 2012
Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumoursLeonid Gibiansky, Liviawati Sutjandra, Sameer Doshi, et al.
Clinical Pharmacokinetics|December 21, 2024
Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin LymphomaTommy Li, Leonid Gibiansky, Apurvasena Parikh, et al.
Clinical Pharmacokinetics|August 1, 2026
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular LymphomaMahipal Sinnollareddy, Kinjal Sanghavi, Leonid Gibiansky, et al.
Pageof 6